LB Pharmaceuticals Inc <LBRX.O>: Leerink Partners Raises Target Price to $55 From $40
LBRX•Related News
Oil rises as doubts over US-Iran deal heighten supply concerns
XLE•
Cardinal Health, Inc. <CAH.N>: Leerink Partners raises target price to $292 from $275
CAH•
Natera, Inc. <NTRA.O>: Guggenheim Raises Target Price to $360 From $290
NTRA•
10X Genomics, Inc. <TXG.O>: Stephens Raises Target Price to $65 From $50
TXG•
Wheat rises on Black Sea disruptions; market eyes USDA report
WEAT•